Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Tax Withholding of 11,632 RNA shares, $104.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Atrium Therapeutics, Inc. (RNA) | Tax Withholding | 11,632 | $104.1K |
| Apr 22, 2026 | Atrium Therapeutics, Inc. (RNA) | Grant/Award | 102,500 | n/a |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 80,303 | n/a |
| Dec 19, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 72,000 | n/a |
| Sep 3, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 188 | $8.9K |
| Jun 18, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 911 | $27.5K |
| Jun 4, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 5,875 | $97.8K |
| May 2, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 5,875 | $97.8K |
| Apr 3, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 5,546 | $81.5K |
| Mar 4, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 5,875 | $86.4K |